Comparison of Aliskiren and Amlodipine on Insulin Resistance and Endothelial Dysfunction in Patients With Hypertension and Metabolic Syndrome

Clinical trial NCT00417170 · COMPLETED

Trial details

NCT number: NCT00417170
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

High Blood Pressure Metabolic Syndrome Insulin Resistance Endothelial Dysfunction

Start date: 2007-10-01
Primary completion: 2010-07-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.